vs
Side-by-side financial comparison of Broadway Financial Corp (BYFC) and EyePoint, Inc. (EYPT). Click either name above to swap in a different company.
Broadway Financial Corp is the larger business by last-quarter revenue ($9.4M vs $5.3M, roughly 1.8× EyePoint, Inc.). Broadway Financial Corp runs the higher net margin — 1934.0% vs -1114.3%, a 3048.3% gap on every dollar of revenue. On growth, Broadway Financial Corp posted the faster year-over-year revenue change (10.1% vs -43.7%). Broadway Financial Corp produced more free cash flow last quarter ($-13.0K vs $-63.8M). Over the past eight quarters, Broadway Financial Corp's revenue compounded faster (9.7% CAGR vs -40.8%).
Virtu Financial, Inc. is an American high-frequency trading company. The company went public on the Nasdaq in 2015.
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
BYFC vs EYPT — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.4M | $5.3M |
| Net Profit | $1.0M | $-59.4M |
| Gross Margin | — | — |
| Operating Margin | — | -1166.8% |
| Net Margin | 1934.0% | -1114.3% |
| Revenue YoY | 10.1% | -43.7% |
| Net Profit YoY | -21.8% | -92.8% |
| EPS (diluted) | $0.02 | $-0.85 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.4M | — | ||
| Q3 25 | $9.0M | — | ||
| Q2 25 | $8.1M | $5.3M | ||
| Q1 25 | $8.3M | $24.5M | ||
| Q4 24 | $8.6M | $11.6M | ||
| Q3 24 | $8.7M | $10.5M | ||
| Q2 24 | $8.2M | $9.5M | ||
| Q1 24 | $7.8M | $11.7M |
| Q4 25 | $1.0M | — | ||
| Q3 25 | $-23.9M | — | ||
| Q2 25 | $752.0K | $-59.4M | ||
| Q1 25 | $-2.7M | $-45.2M | ||
| Q4 24 | $1.3M | $-41.4M | ||
| Q3 24 | $516.0K | $-29.4M | ||
| Q2 24 | $256.0K | $-30.8M | ||
| Q1 24 | $-154.0K | $-29.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 93.0% | ||
| Q2 24 | — | 85.2% | ||
| Q1 24 | — | 93.5% |
| Q4 25 | — | — | ||
| Q3 25 | -256.2% | — | ||
| Q2 25 | 12.8% | -1166.8% | ||
| Q1 25 | -45.3% | -199.7% | ||
| Q4 24 | 21.7% | -390.4% | ||
| Q3 24 | 8.5% | -311.2% | ||
| Q2 24 | 4.8% | -364.5% | ||
| Q1 24 | -2.9% | -285.2% |
| Q4 25 | 1934.0% | — | ||
| Q3 25 | -264.2% | — | ||
| Q2 25 | 9.3% | -1114.3% | ||
| Q1 25 | -32.3% | -184.8% | ||
| Q4 24 | 15.3% | -357.3% | ||
| Q3 24 | 5.9% | -279.0% | ||
| Q2 24 | 3.1% | -325.3% | ||
| Q1 24 | -2.0% | -250.6% |
| Q4 25 | $0.02 | — | ||
| Q3 25 | $-2.86 | — | ||
| Q2 25 | $0.00 | $-0.85 | ||
| Q1 25 | $-0.39 | $-0.65 | ||
| Q4 24 | $0.07 | $-0.65 | ||
| Q3 24 | $-0.03 | $-0.54 | ||
| Q2 24 | $0.02 | $-0.58 | ||
| Q1 24 | $-0.02 | $-0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.5M | $255.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $262.8M | $246.0M |
| Total Assets | $1.3B | $301.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.5M | — | ||
| Q3 25 | $19.7M | — | ||
| Q2 25 | $29.5M | $255.7M | ||
| Q1 25 | $15.8M | $318.2M | ||
| Q4 24 | $61.4M | $370.9M | ||
| Q3 24 | $97.1M | $253.8M | ||
| Q2 24 | $89.8M | $280.2M | ||
| Q1 24 | $67.1M | $299.3M |
| Q4 25 | $262.8M | — | ||
| Q3 25 | $261.7M | — | ||
| Q2 25 | $284.7M | $246.0M | ||
| Q1 25 | $283.6M | $298.4M | ||
| Q4 24 | $285.0M | $336.5M | ||
| Q3 24 | $286.2M | $218.7M | ||
| Q2 24 | $282.1M | $228.3M | ||
| Q1 24 | $281.1M | $249.9M |
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.2B | $301.1M | ||
| Q1 25 | $1.3B | $362.6M | ||
| Q4 24 | $1.3B | $418.5M | ||
| Q3 24 | $1.4B | $300.9M | ||
| Q2 24 | $1.4B | $324.2M | ||
| Q1 24 | $1.4B | $329.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $230.0K | $-62.6M |
| Free Cash FlowOCF − Capex | $-13.0K | $-63.8M |
| FCF MarginFCF / Revenue | -0.1% | -1196.5% |
| Capex IntensityCapex / Revenue | 2.6% | 22.9% |
| Cash ConversionOCF / Net Profit | 0.22× | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.3M | $-194.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $230.0K | — | ||
| Q3 25 | $3.8M | — | ||
| Q2 25 | $3.0M | $-62.6M | ||
| Q1 25 | $-4.3M | $-53.1M | ||
| Q4 24 | $1.4M | $-35.8M | ||
| Q3 24 | $6.1M | $-39.0M | ||
| Q2 24 | $9.8M | $-20.2M | ||
| Q1 24 | $-11.7M | $-31.2M |
| Q4 25 | $-13.0K | — | ||
| Q3 25 | $3.7M | — | ||
| Q2 25 | $3.0M | $-63.8M | ||
| Q1 25 | $-4.4M | $-53.4M | ||
| Q4 24 | $1.3M | $-36.2M | ||
| Q3 24 | $6.1M | $-40.6M | ||
| Q2 24 | $9.7M | $-21.1M | ||
| Q1 24 | $-11.7M | $-32.4M |
| Q4 25 | -0.1% | — | ||
| Q3 25 | 41.1% | — | ||
| Q2 25 | 37.0% | -1196.5% | ||
| Q1 25 | -52.4% | -218.4% | ||
| Q4 24 | 14.7% | -312.7% | ||
| Q3 24 | 69.6% | -385.8% | ||
| Q2 24 | 118.9% | -222.4% | ||
| Q1 24 | -149.7% | -277.0% |
| Q4 25 | 2.6% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 0.2% | 22.9% | ||
| Q1 25 | 0.2% | 1.1% | ||
| Q4 24 | 1.6% | 3.3% | ||
| Q3 24 | 0.3% | 15.0% | ||
| Q2 24 | 0.5% | 9.5% | ||
| Q1 24 | 0.7% | 10.2% |
| Q4 25 | 0.22× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.00× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.06× | — | ||
| Q3 24 | 11.85× | — | ||
| Q2 24 | 38.21× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
